Thistlethwaite Protocol ITN025ST - Immunosuppression with Campath-1H [alemtuzumab] and tacrolimus in liver transplantation.
Phase of Trial: Phase II
Latest Information Update: 20 May 2011
At a glance
- Drugs Alemtuzumab (Primary) ; Tacrolimus
- Indications Liver transplant rejection
- Focus Therapeutic Use
- 10 Dec 2008 Updated end date as reported by ClinicalTrials.gov record.
- 10 Dec 2008 Status changed from recruiting to completed. as reported in ClinicalTrials.gov record.
- 02 Dec 2005 New trial record.